Children With Surgically Corrected Acyanotic Congenital Heart Disease

Starting soon · Not applicable

Conditions studied: Acyanotic Congenital Heart Disease

In brief

The goal of this quasi-experimental pretest-posttest controlled study is to learn whether moderate-intensity treadmill exercise can improve gait kinematics, walking capacity, and motor performance in preschool children aged 48-72 months with surgically corrected acyanotic congenital heart disease. The main questions it aims to answer are: Does moderate-intensity treadmill training improve gait kinematics, including stride length, walking speed, and double-stance percentage? Does moderate-intensity treadmill training improve walking capacity and balance in children with surgically corrected acyanotic congenital heart disease? Researchers compared children with surgically corrected acyanotic congenital heart disease who received treadmill training with age-matched healthy children to see whether the exercise program could reduce gait, balance, and walking-capacity differences between the groups. Participants with congenital heart disease completed: Four treadmill walking sessions per week for 10 weeks. Moderate-intensity walking at approximately 70% of maximal heart rate. Pre- and post-intervention assessments of gait kinematics using three-dimensional motion analysis. Balance assessment using the Pediatric Balance Scale. Walking capacity assessment using the six-minute walk test.

Key facts

Study ID

NCT07605832

Run by

Delta University for Science and Technology

People needed

80

Starts

2026-05-31

Expected to finish

2026-09-01

Last updated by the study team

2026-05-26

Who can join

Age: 4 and older, up to 6. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• For cyanotic postoperative congenital heart disease group:
• Children diagnosed with acyanotic postoperative congenital heart disease.
• Underwent surgical repair for CHD.
• Has a history of only one surgical intervention.
• Age between 48 and 72 months.
• Mentally normal, with an IQ between 85 and 115.
• For the healthy control group (HCG):
• For healthy children aged 48 to 72 months. Full school attendance. Full participation in social and recreational activities. Parents/guardians provided written informed consent.

You may not qualify if…

• Children were excluded if they had:
• Genetic disorders.
• Severe neurological disorders.
• Cyanotic congenital heart disease.
• Perinatal complications.

Where it is running

• Amira Hussin Mohammed — Gamasa, Egypt

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.